| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.67e-05 | 118 | 32 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.33e-05 | 614 | 32 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.24e-05 | 441 | 32 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.86e-04 | 775 | 32 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.90e-04 | 70 | 32 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.02e-04 | 839 | 32 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.04e-04 | 840 | 32 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.04e-04 | 840 | 32 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 3.33e-04 | 17 | 32 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 4.18e-04 | 19 | 32 | 2 | GO:0032794 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 4.64e-04 | 20 | 32 | 2 | GO:0140036 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 7.29e-04 | 25 | 32 | 2 | GO:0140035 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 1.97e-05 | 217 | 32 | 5 | GO:0000075 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 3.63e-05 | 854 | 32 | 8 | GO:1903047 | |
| GeneOntologyBiologicalProcess | cell cycle process | 4.17e-05 | 1441 | 32 | 10 | GO:0022402 | |
| GeneOntologyBiologicalProcess | DNA integrity checkpoint signaling | 7.23e-05 | 145 | 32 | 4 | GO:0031570 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 1.09e-04 | 311 | 32 | 5 | GO:1901988 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 1.21e-04 | 1014 | 32 | 8 | GO:0000278 | |
| GeneOntologyBiologicalProcess | maintenance of organelle location | 1.80e-04 | 13 | 32 | 2 | GO:0051657 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 2.21e-04 | 362 | 32 | 5 | GO:0010948 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 2.59e-04 | 845 | 32 | 7 | GO:0010564 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 3.56e-04 | 627 | 32 | 6 | GO:0044770 | |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 4.26e-04 | 95 | 32 | 3 | GO:0044774 | |
| HumanPheno | Hypoplasia of the corpus callosum | 3.20e-05 | 478 | 12 | 7 | HP:0002079 | |
| Domain | P-loop_NTPase | 5.43e-05 | 848 | 31 | 8 | IPR027417 | |
| Domain | Apc4_WD40_dom | 4.97e-04 | 20 | 31 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.97e-04 | 20 | 31 | 2 | PF12894 | |
| Domain | PDZ | 1.62e-03 | 141 | 31 | 3 | PF00595 | |
| Domain | AAA+_ATPase | 1.72e-03 | 144 | 31 | 3 | IPR003593 | |
| Domain | AAA | 1.72e-03 | 144 | 31 | 3 | SM00382 | |
| Domain | PDZ | 1.86e-03 | 148 | 31 | 3 | SM00228 | |
| Domain | - | 1.94e-03 | 150 | 31 | 3 | 2.30.42.10 | |
| Domain | PDZ | 1.97e-03 | 151 | 31 | 3 | PS50106 | |
| Domain | PDZ | 2.01e-03 | 152 | 31 | 3 | IPR001478 | |
| Domain | Kinesin_motor_CS | 2.10e-03 | 41 | 31 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.31e-03 | 43 | 31 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 2.42e-03 | 44 | 31 | 2 | PS00411 | |
| Domain | - | 2.42e-03 | 44 | 31 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 2.42e-03 | 44 | 31 | 2 | IPR001752 | |
| Domain | Kinesin | 2.42e-03 | 44 | 31 | 2 | PF00225 | |
| Domain | KISc | 2.42e-03 | 44 | 31 | 2 | SM00129 | |
| Domain | KINESIN_MOTOR_2 | 2.42e-03 | 44 | 31 | 2 | PS50067 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.49e-03 | 53 | 31 | 2 | IPR011047 | |
| Domain | - | 7.19e-03 | 746 | 31 | 5 | 3.40.50.300 | |
| Domain | WD40 | 8.90e-03 | 259 | 31 | 3 | PF00400 | |
| Domain | Rho_GTPase_activation_prot | 9.34e-03 | 88 | 31 | 2 | IPR008936 | |
| Domain | WD40 | 9.76e-03 | 268 | 31 | 3 | SM00320 | |
| Domain | WD40_repeat | 1.02e-02 | 272 | 31 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.08e-02 | 278 | 31 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.09e-02 | 279 | 31 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.09e-02 | 279 | 31 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 1.29e-02 | 297 | 31 | 3 | IPR017986 | |
| Domain | - | 1.75e-02 | 333 | 31 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.77e-02 | 335 | 31 | 3 | IPR015943 | |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 6.51e-08 | 9 | 33 | 3 | 38651641 | |
| Pubmed | Cell polarity and spindle orientation in the distal epithelium of embryonic lung. | 9.30e-08 | 10 | 33 | 3 | 21246661 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.53e-07 | 341 | 33 | 6 | 32971831 | |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.35e-06 | 86 | 33 | 4 | 10862698 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21172391 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19615412 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23525105 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 12925752 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 28115485 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 10196137 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.29e-05 | 934 | 33 | 7 | 33916271 | |
| Pubmed | 2.78e-05 | 963 | 33 | 7 | 28671696 | ||
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 9300697 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 26755700 | ||
| Pubmed | Primary cilium migration depends on G-protein signalling control of subapical cytoskeleton. | 3.91e-05 | 10 | 33 | 2 | 23934215 | |
| Pubmed | Gradual centriole maturation associates with the mitotic surveillance pathway in mouse development. | 4.78e-05 | 11 | 33 | 2 | 33410253 | |
| Pubmed | Telophase correction refines division orientation in stratified epithelia. | 5.73e-05 | 12 | 33 | 2 | 31833472 | |
| Pubmed | Intrinsic neural stem cell properties define brain hypersensitivity to genotoxic stress. | 5.73e-05 | 12 | 33 | 2 | 35623353 | |
| Pubmed | Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. | 1.04e-04 | 16 | 33 | 2 | 15037549 | |
| Pubmed | Daple coordinates organ-wide and cell-intrinsic polarity to pattern inner-ear hair bundles. | 1.32e-04 | 18 | 33 | 2 | 29229865 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.38e-04 | 857 | 33 | 6 | 25609649 | |
| Pubmed | 1.48e-04 | 19 | 33 | 2 | 19666823 | ||
| Pubmed | EMX2-GPR156-Gαi reverses hair cell orientation in mechanosensory epithelia. | 1.99e-04 | 22 | 33 | 2 | 34001891 | |
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 12812986 | ||
| Pubmed | 2.45e-04 | 128 | 33 | 3 | 23858473 | ||
| Pubmed | Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo. | 3.02e-04 | 27 | 33 | 2 | 24706806 | |
| Pubmed | 3.25e-04 | 1429 | 33 | 7 | 35140242 | ||
| Pubmed | 3.49e-04 | 29 | 33 | 2 | 25681748 | ||
| Pubmed | 3.53e-04 | 653 | 33 | 5 | 22586326 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 4.04e-04 | 370 | 33 | 4 | 22922362 | |
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 5.09e-04 | 35 | 33 | 2 | 32907846 | |
| Pubmed | 5.34e-04 | 1103 | 33 | 6 | 34189442 | ||
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 5.69e-04 | 37 | 33 | 2 | 11416179 | |
| Pubmed | 5.78e-04 | 407 | 33 | 4 | 12693553 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.94e-04 | 410 | 33 | 4 | 26949251 | |
| Pubmed | 6.01e-04 | 38 | 33 | 2 | 25613138 | ||
| Pubmed | 6.39e-04 | 418 | 33 | 4 | 34709266 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.80e-04 | 1155 | 33 | 6 | 20360068 | |
| Pubmed | 7.88e-04 | 191 | 33 | 3 | 20195357 | ||
| Pubmed | 8.62e-04 | 453 | 33 | 4 | 29656893 | ||
| Interaction | DYNLL1 interactions | 1.54e-05 | 510 | 33 | 7 | int:DYNLL1 | |
| Cytoband | 10p12.1 | 2.45e-04 | 32 | 33 | 2 | 10p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 3.27e-03 | 415 | 33 | 3 | chr12q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p12 | 4.58e-03 | 140 | 33 | 2 | chr10p12 | |
| GeneFamily | PDZ domain containing | 7.98e-04 | 152 | 22 | 3 | 1220 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.42e-03 | 46 | 22 | 2 | 622 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.67e-03 | 50 | 22 | 2 | 721 | |
| GeneFamily | WD repeat domain containing | 3.78e-03 | 262 | 22 | 3 | 362 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.02e-02 | 718 | 22 | 4 | 28 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 3.61e-06 | 194 | 32 | 5 | M7467 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 2.07e-05 | 105 | 33 | 4 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 9.17e-05 | 1257 | 33 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 1.60e-04 | 68 | 33 | 3 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k1_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 1.71e-04 | 1060 | 33 | 8 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 1.77e-04 | 1370 | 33 | 9 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 2.25e-04 | 1414 | 33 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 2.84e-04 | 1459 | 33 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.06e-06 | 179 | 33 | 4 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-05 | 196 | 33 | 4 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 196 | 33 | 4 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 196 | 33 | 4 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-05 | 196 | 33 | 4 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 196 | 33 | 4 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-05 | 196 | 33 | 4 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 1.32e-05 | 197 | 33 | 4 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 198 | 33 | 4 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 198 | 33 | 4 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.35e-05 | 198 | 33 | 4 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 198 | 33 | 4 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 1.37e-05 | 199 | 33 | 4 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.40e-05 | 200 | 33 | 4 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.40e-05 | 200 | 33 | 4 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-05 | 200 | 33 | 4 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 130 | 33 | 3 | 1720f16ac06951c3f57b6c3b0944670a571203d1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-04 | 150 | 33 | 3 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 154 | 33 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 154 | 33 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-04 | 162 | 33 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.48e-04 | 166 | 33 | 3 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-04 | 167 | 33 | 3 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.75e-04 | 172 | 33 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 172 | 33 | 3 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-04 | 172 | 33 | 3 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 172 | 33 | 3 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-04 | 172 | 33 | 3 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 2.75e-04 | 172 | 33 | 3 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-04 | 176 | 33 | 3 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 2.99e-04 | 177 | 33 | 3 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-04 | 178 | 33 | 3 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-04 | 179 | 33 | 3 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 3.15e-04 | 180 | 33 | 3 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 181 | 33 | 3 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 181 | 33 | 3 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 3.30e-04 | 183 | 33 | 3 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.30e-04 | 183 | 33 | 3 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.30e-04 | 183 | 33 | 3 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 3.35e-04 | 184 | 33 | 3 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-04 | 184 | 33 | 3 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 184 | 33 | 3 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 185 | 33 | 3 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 3.63e-04 | 189 | 33 | 3 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-04 | 189 | 33 | 3 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-04 | 189 | 33 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.74e-04 | 191 | 33 | 3 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-04 | 191 | 33 | 3 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.74e-04 | 191 | 33 | 3 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.74e-04 | 191 | 33 | 3 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.74e-04 | 191 | 33 | 3 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 192 | 33 | 3 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 192 | 33 | 3 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.80e-04 | 192 | 33 | 3 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-04 | 192 | 33 | 3 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 3.86e-04 | 193 | 33 | 3 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.92e-04 | 194 | 33 | 3 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.92e-04 | 194 | 33 | 3 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.97e-04 | 195 | 33 | 3 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.97e-04 | 195 | 33 | 3 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.97e-04 | 195 | 33 | 3 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.97e-04 | 195 | 33 | 3 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 196 | 33 | 3 | 34bd155e6d848eb53d613997c0e244535de30ba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-04 | 196 | 33 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 196 | 33 | 3 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.03e-04 | 196 | 33 | 3 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 4.03e-04 | 196 | 33 | 3 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.03e-04 | 196 | 33 | 3 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.09e-04 | 197 | 33 | 3 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.09e-04 | 197 | 33 | 3 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 4.09e-04 | 197 | 33 | 3 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.09e-04 | 197 | 33 | 3 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 197 | 33 | 3 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.09e-04 | 197 | 33 | 3 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 197 | 33 | 3 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.09e-04 | 197 | 33 | 3 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | 5c14b152912429f099dfcb6bcb1aec80314a3284 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-04 | 198 | 33 | 3 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | distal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | aa23119d73554733981df474648e59918d04edfc | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.16e-04 | 198 | 33 | 3 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.16e-04 | 198 | 33 | 3 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.16e-04 | 198 | 33 | 3 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.16e-04 | 198 | 33 | 3 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-04 | 198 | 33 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.16e-04 | 198 | 33 | 3 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.16e-04 | 198 | 33 | 3 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.16e-04 | 198 | 33 | 3 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-04 | 198 | 33 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 4.22e-04 | 199 | 33 | 3 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-04 | 199 | 33 | 3 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| Disease | urgency urinary incontinence | 6.55e-05 | 12 | 30 | 2 | EFO_0006865 | |
| Disease | Chronic myeloproliferative disorder | 1.69e-04 | 19 | 30 | 2 | C1292778 | |
| Disease | Seckel syndrome | 2.28e-04 | 22 | 30 | 2 | C0265202 | |
| Disease | left ventricular ejection fraction measurement | 7.61e-04 | 40 | 30 | 2 | EFO_0008373 | |
| Disease | heart rate | 1.53e-03 | 225 | 30 | 3 | EFO_0004326 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.76e-03 | 61 | 30 | 2 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | Schizophrenia | 1.82e-03 | 883 | 30 | 5 | C0036341 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 1.82e-03 | 62 | 30 | 2 | EFO_0004918, MONDO_0005147 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.94e-03 | 64 | 30 | 2 | EFO_0008405 | |
| Disease | aortic measurement | 2.08e-03 | 251 | 30 | 3 | EFO_0020865 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.12e-03 | 67 | 30 | 2 | EFO_0008595, EFO_0020946 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.18e-03 | 68 | 30 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | mitochondrial heteroplasmy measurement | 2.25e-03 | 69 | 30 | 2 | EFO_0600008 | |
| Disease | serum albumin measurement | 2.90e-03 | 592 | 30 | 4 | EFO_0004535 | |
| Disease | alkaline phosphatase measurement | 3.32e-03 | 1015 | 30 | 5 | EFO_0004533 | |
| Disease | Neurodevelopmental Disorders | 4.04e-03 | 93 | 30 | 2 | C1535926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VHFEVDTSHEKVESM | 16 | Q8TC20 | |
| RTIIMSTHHMDEADL | 1111 | P78363 | |
| DSQEAMMDHALHTIS | 281 | O96018 | |
| TLENMMQRHEEEAHE | 741 | O14578 | |
| DMEEQHVIHMLTGHT | 896 | Q149M9 | |
| MEENLISMREDHSFH | 1 | P81274 | |
| MSVTEEDLCHHMKVV | 1 | Q8NI77 | |
| VVDHMTIHMDDSDSI | 2676 | Q2LD37 | |
| LMDLHMDHEGSSQET | 491 | Q14C86 | |
| MEEHGVTQTEHMATI | 1 | Q16656 | |
| AEMSSVAEISSHMRE | 1226 | O95613 | |
| MSMEEYDIVHLEHET | 791 | P29475 | |
| VTIAHSMEAVDEMFS | 746 | Q13415 | |
| SAEHPESMMSEVHER | 1316 | Q6ZP82 | |
| SEMQIAKSDSIHHMS | 36 | Q8TD57 | |
| IMQMVEDTLIEHAHT | 741 | P14735 | |
| TVEDMVSFHHRKEMI | 1071 | Q6ZMW3 | |
| EAMHIMGFSHEEILS | 331 | P35580 | |
| TVSEEATEVHMMEGD | 201 | P0C7A2 | |
| MHTVHSVAQCEHIME | 176 | Q9P2E2 | |
| MVSVINTVDTSHEDM | 1 | P55735 | |
| HEDETTNRMHESLML | 236 | P09471 | |
| SELVMMHDDESTINS | 376 | Q9H2K8 | |
| LREEAHNMGTIHMSE | 586 | Q9BTA9 | |
| VPEAVSDMLMSEFHH | 1621 | Q8N2C7 | |
| EDMDSLLLHHRSMES | 566 | Q5TG30 | |
| CHELFVEETSLMNHM | 286 | Q96K83 | |
| HVISTEEGDMMETNS | 841 | Q9H0E3 | |
| ATSDVMSESMVETHD | 951 | Q12888 | |
| RETHMMGNEEETEFH | 401 | Q8IUF8 | |
| EMFTHMNSLSEETDH | 176 | P0CG31 | |
| QQDMISHDELMVHEE | 71 | Q9UQR1 | |
| LVRTSEDNMTHMVTH | 1306 | Q5T5U3 | |
| MPEHVLTSESMHVCD | 131 | P08048 |